Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suraj Bala

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
American Journal of Ophthalmology|April 12, 2026
Reply to Comment on: Impact of Phacoemulsification on Vitreomacular Traction Release and ComplicationsSuraj Bala, Nitesh Mohan, Victor Bellanda, et al.
American Journal of Ophthalmology|June 23, 2026
Associations Between Routine Vaccinations and the Risk of New-Onset Idiopathic UveitisMatthew J Schulgit, Suraj Bala, Victor Bellanda, et al.
Ophthalmology. Retina|November 6, 2025
Glucagon-Like Peptide-1 Receptor Agonist Use and Risk of Neovascular Age-Related Macular Degeneration in a National Cohort StudyKevin C Allan, Erin F Cohn, Suraj Bala, et al.
Ophthalmology. Retina|September 11, 2025
Screening for Retinal Ischemic Perivascular Lesions in Patients Undergoing Cardiovascular Assessment: A Cross-Sectional StudyVictor Bellanda, Adrienne Delaney, Matthew J Schulgit, et al.
Journal of Vitreoretinal Diseases|October 7, 2025
Real-World Functional and Anatomic Outcomes With Aflibercept 8.0 mg in Patients With Diabetic Macular EdemaGabriel Castilho S Barbosa, Suraj Bala, Nitesh Mohan, et al.
Ophthalmology. Retina|February 9, 2025
Initial Functional and Anatomical Outcomes of High-dose Aflibercept 8 mg in Exudative Neovascular Age-related Macular DegenerationSuraj Bala, Gabriel C S Barbosa, Nitesh Mohan, et al.
Journal of Vitreoretinal Diseases|April 21, 2026
Quality Improvement in Vitreoretinal Surgery: Single-Center Report on Utility of Routine Intravenous Fluids in Pars Plana VitrectomyJoseph R Abraham, Andrea Arline, Suraj Bala, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
American Journal of Ophthalmology|April 12, 2026
Reply to Comment on: Impact of Phacoemulsification on Vitreomacular Traction Release and ComplicationsSuraj Bala, Nitesh Mohan, Victor Bellanda, et al.
American Journal of Ophthalmology|June 23, 2026
Associations Between Routine Vaccinations and the Risk of New-Onset Idiopathic UveitisMatthew J Schulgit, Suraj Bala, Victor Bellanda, et al.
Ophthalmology. Retina|November 6, 2025
Glucagon-Like Peptide-1 Receptor Agonist Use and Risk of Neovascular Age-Related Macular Degeneration in a National Cohort StudyKevin C Allan, Erin F Cohn, Suraj Bala, et al.
Ophthalmology. Retina|September 11, 2025
Screening for Retinal Ischemic Perivascular Lesions in Patients Undergoing Cardiovascular Assessment: A Cross-Sectional StudyVictor Bellanda, Adrienne Delaney, Matthew J Schulgit, et al.
Journal of Vitreoretinal Diseases|October 7, 2025
Real-World Functional and Anatomic Outcomes With Aflibercept 8.0 mg in Patients With Diabetic Macular EdemaGabriel Castilho S Barbosa, Suraj Bala, Nitesh Mohan, et al.
Ophthalmology. Retina|February 9, 2025
Initial Functional and Anatomical Outcomes of High-dose Aflibercept 8 mg in Exudative Neovascular Age-related Macular DegenerationSuraj Bala, Gabriel C S Barbosa, Nitesh Mohan, et al.
Journal of Vitreoretinal Diseases|April 21, 2026
Quality Improvement in Vitreoretinal Surgery: Single-Center Report on Utility of Routine Intravenous Fluids in Pars Plana VitrectomyJoseph R Abraham, Andrea Arline, Suraj Bala, et al.
Pageof 2